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Abstract: Alliums and allied plant species are rich sources of sulfur compounds that have effects on
vascular homeostasis and the control of metabolic systems linked to nutrient metabolism in mammals.
In view of the multiple biological effects ascribed to these sulfur molecules, researchers are now using
these compounds as inspiration for the synthesis and development of novel sulfur-based therapeutics.
This research has led to the chemical synthesis and biological assessment of a diverse array of sulfur
compounds representative of derivatives of S-alkenyl-l-cysteine sulfoxides, thiosulfinates, ajoene
molecules, sulfides, and S-allylcysteine. Many of these synthetic derivatives have potent antimicrobial
and anticancer properties when tested in preclinical models of disease. Therefore, the current review
provides an overview of advances in the development and biological assessment of synthetic analogs
of allium-derived sulfur compounds.
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1. Introduction
Approximately 700 plant species are known to contain S-alk(en)yl-l-cysteine sulfoxides (ACSOs),
including many edibles like allium and brassica vegetables (Table 1). Popularity stems from their
distinctive flavors, produced during the breakdown of each respective ACSOs [1,2]. As such, changes
to the composition and quantities of each ACSO determines the odor, flavor variation, and biological
activities ascribed to many plants containing these sulfur storage compounds [3]. At present, four
major and two minor ACSOs exist, and these act as progenitor molecules in the production of other
sulfur compounds like the lachrymatory factor, propanethial S-oxide and the antimicrobial compound
allicin [3]. An additional 50+ sulfur compounds, including thiosulfinates, cysteine, and sulfides
derivatives can also occur in allium tissue following preparation, and many of these compounds
possess some level of biological activity in mammalian cells and tissue [4]. Indeed, researchers have
shown crude allium-derived plant extracts as well as isolated sulfur compounds such as S-allylcysteine,
diallyl disulfide, allicin, 1,2-vinyldithiin, 3-vinyldithiin, and ajoene can induce a range of physiological
and biochemical changes in mammalian systems [5]. For example, several cellular targets are reported
to be susceptible to sulfur compound treatment, including proinflammatory transcription factor nuclear
factor-kappa beta (NF-κB) [6,7], various kinases, including p38 mitogen-activated protein kinase (p38
MAPK) [8], c-JunNH2-terminal kinase (JNK) [9], extracellular signal-regulated kinase (ERK) [10], and
phosphoinositide 3-kinase-protein kinase B (PI-3K-Akt) [11]. Other cellular proteins, like nuclear
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factor erythroid 2-related factor 2 (Nrf-2) [12–14], p53 [15,16], AMP-activated protein kinase [17,18],
proliferator-activated receptor γ [19], and NAD-dependent deacetylase sirtuin-1 (SIRT1) [20] are also
targets of allium-derived sulfur species. Consequently, many sulfur molecules have been reported to
have anticancer properties [21–24], are anti-inflammatory [7,25–27], act as cytoprotective agents [28,29],
function as inhibitors of metastasis [30,31], and alter lipid metabolism [32,33]. Additionally, molecules
like diallyl trisulfide (DATS) release hydrogen sulfide gas (H2S) in the presence of glutathione and
cysteine [34]. The liberated H2S acts as a gaseous signaling molecule in mammalian cells with potential
pharmacological effects in humans [35,36]. This property may contribute to the biological effects
attributed to DATS and, more widely, other allium-derived sulfur species [37]. The identification of
these molecular targets may explain why several ACSOs containing plant species, including garlic
(Allium sativum) and onion (A. cepa) are common constituents of folklore remedies [38–40]. Moreover,
several human population-based studies have shown that the consumption of diets rich in allium and
brassica vegetables are associated with a reduced risk of developing several forms of cancers [41,42],
type II diabetes [43], cardiovascular diseases [44,45], and changes in the gut microbiome [46].
Table 1. Allium and brassica S-Alk(en)yl-l-cysteine sulfoxides (adapted from [2]).
Chemical Name Structure Species
S-Methyl-l-Cysteine Sulfoxide
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 A. cepa 
A. nutans 
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A. cepa
A. sativum
A. chinensis
Brassica Oleracea
S-Allyl-l-Cysteine Sulfoxide
Molecules 2019, 24, x FOR PEER REVIEW 2 of 17 
 
3K-Akt) [11]. ther cellular proteins, like nuclear factor erythroid 2-related factor 2 (Nrf-2) [12–14], 
p53 [15,16], AMP-activated protein kinase [17,18], proliferator-activated receptor γ [19], and NAD-
dependent deacetylase sirtuin-1 (SIRT1) [20] are also targets of allium-derived sulfur species. 
Consequently, many sulfur molecules have been reported to have anticancer properties [21–24], are 
anti-inflammatory [7,25–27], act as cytoprotective agents [28,29], function as inhibitors of metastasis 
[30,31], and alter lipid metabolism [32,33]. Additionally, molecules like diallyl trisulfide (DATS) 
release hydrogen sulfide gas (H2S) in the presence of glutathione and cysteine [34]. The liberated H2S 
acts as a gaseous signaling molecule in mammalian cells with potential pharmacological effects in 
humans [35,36]. This property may contribute to the biological effects attributed to DATS and, more 
widely, other allium-derived sulfur species [37]. The identification of these molecular targets may 
explain why several ACSOs containing plant species, including garlic (Allium sativum) and onion (A. 
cepa) are common constituents of folklore remedies [38–40]. Moreover, several human population-
based studies have shown that the consumption of diets rich in allium and brassica vegetables are 
associated with a reduced risk of developing several forms of cancers [41,42], type II diabetes [43], 
cardiovascular diseases [44,45], and changes in the gut microbiome [46].  
Table 1. Allium and brassica S-Alk(en)yl-L-cysteine sulfoxides (adapted from [2]). 
Chemical Name Structure Species 
S-Methyl-L-Cysteine Sulfoxide  A. cepa 
A. sativum 
A. chinensis 
Brassica Oleracea 
S-Allyl-L-Cysteine Sulfoxide  A. sativum 
A. ursinium 
A. ampeloprasum 
S-Propyl-L-Cysteine Sulfoxide  A. cepa 
A. porrum 
A. fistulosum 
S-Propenyl-L-Cysteine 
Sulfoxide 
 A. cepa 
A. nutans 
A. schoenoprasum 
S-Ethyl-L-Cysteine Sulfoxide  A. aflatunense 
A. ampeloprasum 
A. victorialis 
S-n-Butyl-L-Cysteine Sulfoxide  A. siculum 
A. sativum
A. ursinium
A. ampeloprasum
S-Propyl-l-Cysteine Sulfoxide
Molecules 2019, 24, x FOR PEER REVIEW 2 of 17 
 
3K-Akt) [ 1]. Other cellular proteins, like nuclear factor erythroid 2-related factor 2 (Nrf-2) [12–14],
p53 [15,16], AMP-activated protein kinase [17,18], proliferator-activated receptor γ [19], and NAD-
dependent deacetylase sirtuin-1 (SIRT1) [20] are also targets of allium-derived sulfur species. 
Consequently, many sulfur m lecules have been re orted to have anticancer roperties [21–24], are 
anti-i flammatory [7,25–27], act as cytoprotective agents [28,29], function as inhibitors of metastasis 
[30,31], and alter lipid metab lism [32,33]. Additionally, molecules like diallyl trisulfide (DATS) 
release hydrogen sulfide gas (H2S) in the presenc  of glutathione and cysteine [34]. The liberated H2S 
acts as a gaseous signaling m lecule in mammalian cells with pot ntial pharmacological effects in 
humans [35,36]. This property may contribut  to the biological ffects attributed to DATS and, more 
widely, other allium-derived sulf r species [37]. The identificati n of these molecular targets may 
explai  why several ACSOs cont ining plant species, including garlic (Allium sativum) and onion (A. 
cepa) are common constitu nt  of folklore remedies [38–40]. Moreover, s veral hum n population-
based studie  have shown that the consumption of diets rich in llium and brassica vegetables are 
associat d with a reduced risk f developing s veral forms of cancers [41,42], type II diabetes [43], 
c rdiovascular dis ases [44,45], and changes in the gut microbiome [46].  
Table 1. Allium and brassica S-Alk(en)yl-L-cyste ne sulfoxides (adapted from [2]). 
Chemical Name Structure Species 
S-Methyl-L-Cysteine Sulfoxide  A. cepa 
A. sativu  
. chinensis 
Brassica Oleracea 
S-Allyl-L-Cysteine Sulfoxide  A. sativum 
A. ursinium 
. ampeloprasum 
S-Propyl-L-Cysteine Sulfoxide  A. cepa 
A. porrum 
. fistulosum 
S-Propenyl-L-Cysteine 
Sulfoxide 
 A. cepa 
A. nutans 
. schoenoprasum 
S-Ethyl-L-Cysteine Sulfoxide  A. aflatunense 
A. ampeloprasum 
. victorialis 
S-n-Butyl-L-Cysteine Sulfoxide  A. siculum 
A. cepa
A. porrum
A. fistulosum
S-Propenyl-l-Cysteine Sulfoxide
Molecules 2019, 24, x FOR PEER REVIEW 2 of 17 
 
3K-Akt) [11]. Other cellular proteins, like nuclear factor erythroid 2-related factor 2 (Nrf-2) [12–14], 
p53 [15,16], AMP-activated protein kinase [17,18], proliferator-activated receptor γ [19], and NAD-
dependent deacetylase sirtuin-1 (SIRT1) [20] are also targets of allium-derived sulfur species. 
Consequently, many sulfur molecules have been reported to have anticancer properties [21–24], are 
anti-inflammatory [7,25–27], act as cytoprotective agents [28,29], function as inhibitors of metastasis 
[30,31], and alter lipid metabolism [32,33]. Additionally, molecules like diallyl trisulfide (DATS) 
release hydrogen sulfide gas (H2S) in the presence of glu ath one and cysteine [34]. The liberated H2S 
acts as a gaseous signaling molecule in mammalian cells with potential pharmacological effects in 
humans [35,36]. This property may contribute to the biological effects attribute  to DATS and, more 
widely, other allium-derived sulfur speci s [37]. The identific tion of these molecular targets may 
explain why several ACSOs containing plant specie , including garlic (Allium sativum) and onion (A. 
cepa) are common constituents of folklore remedies [38–40]. Moreover, several h man population-
based studies have shown that the consumption of diets rich in allium and brassica veg tables are 
ssociated with a reduced risk of developing several forms f cancers [41,42], type II diabetes [43], 
cardiovascular diseases [44,45], and changes in the gut microbiome [46].  
Table 1. Allium and brassica S-Alk(en)yl-L-cysteine sulfoxides (adapted from [2]). 
Chemical Name Structure Species 
S-Methyl-L-Cyst ine Sulfoxide  A. cepa 
A. sativum 
A. chinensis 
Brassica Oleracea 
S-Al yl L-Cysteine Sulfoxide  A. sativum 
A. rsinium 
A. ampeloprasum 
-Propyl-L-Cysteine Sulfoxide  cepa 
porrum 
A. fistulosum 
S-Propenyl-L-Cysteine 
ulfoxide 
 A. cepa 
A. nutans 
A. schoenoprasum 
S-Ethyl-L-Cysteine Sulfoxide  . aflatunense 
A. ampeloprasum 
A. victorialis 
S-n-Butyl-L-Cysteine Sulfoxide  . siculum 
A. cepa
A. nutans
A. schoenoprasum
-Ethyl-l-Cysteine Sulfoxide
Molecules 2019, 24, x FOR PEER REVIEW 2 of 17 
 
3K-Akt) [11]. Other cellular proteins, like nuclear factor erythroid 2-related factor 2 (Nrf-2) [12–14], 
p53 [15,16], AMP-activated protein kinase [17,18], proliferator-activated receptor γ [19], and NAD-
dependent deacetylase sirtuin-1 (SIRT1) [20] are also targets of allium-derived sulfur species. 
Consequently, many sulfur molecules have be n reported to have antic ncer pr perties [21–24], are
anti-inflammatory [7,25–27], act as cytoprotective agents [28,29], func ion as inhibitors of metastasis 
[30,31], and alter lipid me abolism [32,33]. Additionally, molecules ike diallyl trisulfide (DATS)
release hydrogen sulfide gas (H2S) in the pres nce of glutathione and cysteine [34]. The liberated H2S
cts as a gaseous signaling molecule in mammali n cells with poten al pharmacological effec s in
humans [35 36]. Th s prop rty may contribute to the bio ogical ffect attributed to DATS and, more
widely, other allium-derived sulfur sp cies [37]. Th  identification of th se molecular targets may
explain why several ACSOs containing plant spec es, including garlic (A lium sativum) and onion (A.
cepa) are common constituents of folklo e remedies [38–40]. Mor over, s veral h man populati n-
based studi s have shown that the consumption of iets rich in allium and brassica vegetables are
assoc ated with a reduced risk of develop g several forms of cancers [41,42], type II diabetes [43],
ardiovas ular disease  [44,45], and changes in the gut icrobiom  [46].  
Table 1. Allium and brassica S-Alk(en)yl-L-cysteine sulfoxides (adapted from [2]). 
Chemical Nam  Struct re Species 
S-Methyl-L-Cysteine Sulfoxide  A. cepa 
A. sativum 
A. ch nensis 
Brassica Ole acea 
S-Allyl-L-Cysteine Sulfoxide  A. sativum 
A. ursinium 
A. ampeloprasum 
S-Propyl-L-Cysteine Sulfoxide  A. cepa 
. porrum 
. fistulosum 
S-Propenyl-L-Cysteine 
Sulfoxide 
 A. cepa 
A. nutans 
A. schoenoprasum 
S-Ethyl-L-Cysteine Sulfoxide  A. aflatunense 
. ampeloprasum 
. vic orialis 
S-n-Butyl-L-Cysteine Sulfoxide  A. siculum 
A. aflatunense
A. ampeloprasum
A. victorialis
S-n-Butyl-l-Cysteine Sulfoxide
Molecules 2019, 24, x FOR PEER REVIEW 2 of 17 
 
3K-Akt) [11]. Other cellular proteins, like nuclear factor erythroid 2-related factor 2 (Nrf-2) [12–14], 
p53 [15,16], AMP-activated protein kinase [17,18], proliferator-activated receptor γ [19], and NAD-
dependent deacetylase sirtuin-1 (SIRT1) [20] are also targets of al ium-derived sul ur species.
Consequently, many sulfur m lecules have been re orted to have an icancer roperties [21–24], are 
anti-i flammatory [7,25–27], act as cytoprotective agents [28,29], function as inhibitors o  metastasis
[30,31], and alter lipid metab lism [32,33]. Additionally, molecules like di llyl trisulfide (DATS)
release hydrogen sulfide gas (H2S) in he presenc of glutathi ne and cystein  [34]. The libera ed H2S
acts as a gaseous s gnaling m lecule in mammal an cells with pot ntial pharmacological effects in
humans [35,36]. This property may contribute to the biological ffects attributed to DATS and, mo
widely, other allium-derived sulf r species [37]. Th  identificati n of these molecular targets may
expl i  why several ACSOs cont ining plan  species, including garlic (All um sativum) an  oni n (A.
c pa) are common constitu nt  o  folklore remedies [38–40]. Mo ov r, s v al hum n population-
based studie  have shown hat he consumption of di s rich in l um and brassica vegetables are
associated wi h  reduced isk developing s veral f rms of c n ers [41,42], type II diabet  [43],
c r iovascul r d ases [44,45], and chang  in the gut microbiome [46]. 
Table 1. Allium and brassica S-Alk(en)yl-L-cysteine s lf xides (adapted from [2]). 
Chemical Nam  Structure Species 
S-Methyl-L-Cysteine Sulfoxide  A. cepa 
A. sativum 
hinensis 
Brassica Oleracea 
S-Allyl-L-Cysteine Sulfoxide  
ursinium
ampeloprasum
S-Propyl-L-Cysteine Sulfoxide  epa 
A. porrum 
fistulosum 
S-Propenyl-L-Cysteine 
Sulfoxide 
 A. cepa 
. n tans 
schoenoprasum 
S-Ethyl-L-Cysteine Sulfoxide  A. aflatunense 
. ampeloprasum 
victorialis 
S-n-Butyl-L-Cysteine Sulfoxide  A. siculum 
A. siculum
In light of the potential roles of dietary sulfur compounds and their potential impact on health, it
is timely to address some of the lesser-known aspects relating to research o allium-derived sulfur
compounds, that of the biological screening of synthetic analogs of ACSOs and associated degradation
products. Over the last decade, a number of researchers have synthesized a spectrum of synthetic sulfur
compounds, representative of derivatives of thiosulfinates, cysteine analogs, ajoene-based compounds,
and various sulfides. Sulfur-derived functional groups occur in a broad range of pharmaceuticals and
natural products, and facilitated developments in modern drug design [47]. In the case of allium-based
molecules, some are reportedly superior to their natural counterparts, and could be useful in the future
development and design of new sulfur therapeutics, or as tools to explore sulfur metabolic networks in
living organisms. Therefore, the current review describes recent advances in the biological assessment
of some novel sulfur molecules that have been inspired by allium sulfur chemistry.
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2. Allium Sulfur Storage Compounds and Generation of Biologically Active Compounds
For the purposes of this review, only a brief overview of the types of sulfur compounds commonly
encountered in allium and brassica plants is provided. We refer interested readers elsewhere
for additional coverage of allium sulfur biochemistry [1–5]. In brief, the main parental storage
compounds in alliums are (+)-S-allyl-l-cysteine sulfoxide (S-ACSO), commonly known as alliin,
(+)-S-methyl-l-cysteine sulfoxide (methiin; MCSO), (+)-S-propyl-l-cysteine sulfoxide (propiin; PCSO),
and (+)-S-trans-1-propenyl-l-cysteine sulfoxide or isoalliin (TPCSO) [1,2]. Isoalliin is the major sulfoxide
present within intact onion tissue and is the source of the lachrymatory factor, thiopropanal-S-oxide.
(+)-S-methyl-l-cysteine sulfoxide is by far the most ubiquitous, found in varying amounts in the intact
tissue of A. sativum, A. cepa, A. porrum, and A. ursinum L., as well as in some brassica vegetables
(Table 1). Enzymatic hydrolysis of ACSOs by the enzyme alliinase (EC 4.4.1.4) produces pyruvate,
ammonia, and sulfenic acids [48]. Formed sulfenic acids further condense to form thiosulfinates, which
in turn form a spectrum of additional sulfur compounds (Figure 1). These sulfur compounds are
believed to be partly responsible for the reported health benefits attributed to the consumption of
an allium- and brassica-rich diet [38,40–46]. Less widely reported are advances in the synthesis and
biological assessment of allium-based sulfur analogs.
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Figure 1. Catabolism of S-alk(en)yl-l-cysteine sulfoxides (ASCOs) by alliinase enzyme generates a
spectrum of individual sulfur compounds.
3. New Sulfur Compounds Inspired by Allium Metabolites
In recent times, a number of researchers have focused their attention on the development of
novel synthetic sulfur analogs of known allium-derived sulfur compounds. These molecules were
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conceptualized with the view to 1) produce more stable chemical entities with enhanced solubility;
2) develop molecules with specific chemical properties, like the ability to release H2S or nitric oxide
(NO) gas; or 3) possess altered biological activities, such as enhanced anticancer activities, interesting
antioxidant properties, or antimicrobial effects. At present, the chemical derivatives of alliin, allicin,
S-allylcysteine, and garlic-derived sulfides have been reported in the literature. Of these, only a
handful have been evaluated in preclinical models of disease and, as far as we are aware, none tested
on humans (Table S1). Given the resurgent interest in sulfur biochemistry, it is reasonable to discuss
advances in this area, as there is optimism that future research in this field will lead to the development
of newer sulfur therapeutics.
3.1. S-Alk(en)yl-l-cysteine Sulfoxides and Thiosulfinate Analogs
To date, only a handful of studies have focused on the synthesis and evaluation of ASCO analogs.
In 1985, the alliin molecule was isolated from the tissue of A. cepa, and found to inhibit platelet
aggregation [49]. Further work led to the testing of several commercially available alliin derivatives,
and to the identification of S-oxodiallyl disulfide that reportedly inhibits platelet aggregation at similar
concentrations as alliin [50]. ASCO catabolism leads to the formation of thiosulfinates, and this chemical
group has gained considerable interest over the years. Thiosulfinates react with thiol groups in cells,
and this reaction mechanism is responsible for their antimicrobial and antifungal activities [2,51,52].
The electron-withdrawing effect of the oxygen atom generates an electrophilic sulfur center, which can
react with thiolate ions of small-molecular-weight compounds or thiol-containing enzymes. Despite
the potential of using the thiosulfinate allicin as an antimicrobial agent, it is unstable and readily
decomposes or binds to cellular proteins [53,54]. Indeed, when allicin is maintained at 20 ◦C for
20 h, it decomposed to diallyl disulfide (DADS) (66%), diallyl sulfide (DAS) (14%), diallyl trisulfide
(DATS) (9%), and sulfur dioxide (SO2) [55]. For this reason, the development of thiosulfinate-based
therapeutics has been limited. Newer fluorinated and S-aryl alkylthiolsulfinate analogs appear to
have greater chemical stability, and these molecules may be promising in the future developments of
thiosulfinate-based therapeutics [56,57].
Recently, researchers have indeed raised the possibility of designing thiosulfinate-based
prodrugs [58]. In this work, methionine- and cysteine-based compounds were tested. These molecules
required catabolism by the methionine γ-lyase enzyme (MGL, EC 4.4.1.11) in order to generate reactive
thiosulfinate intermediates. MGL can catalyze the γ- and β-elimination of methionine, and the cysteine
analogs of l-methionine, l-methionine sulfoxide, S-ethyl-l-homocysteine, S-ethyl-l-homocysteine
sulfoxide, O-acetyl-l-homoserine, S-ethyl-l-cysteine, S-ethyl-l-cysteine sulfoxide, and O-acetyl-l-serine
and alliin. Of the tested compounds, l-methionine sulfoxide, alliin, S-ethyl-l-cysteine, and
S-ethyl-l-homocysteine had bacteriostatic effects towards Citrobacter freundii and Staphylococcus
aureus [58]. Similarly, Leontiev et al. focused on the synthesis of several antimicrobial analogs
of allicin [59]; these compounds were representative of dimethyl-, diethyl-, diallyl-, allicin, dipropyl-,
and dibenzyl- thiosulfinate derivatives (Figure 2A–E). In tests, MICs for the tested bacteria were in the
range of 8–256 µg mL−1 and MBCs in the range of 16–256 µg mL−1 for various thiosulfinates. DMTS
was more active against P. fluorescens than allicin was.
Other researchers have explored the use of thiosulfinates as novel anticancer agents. In the work
of Roseblade et al., the synthesis and biological assessment of a series of 22 aromatic and aliphatic
thiosulfinates were determined. These compounds were screened in an in vitro breast-cancer model
using human adenocarcinoma breast-cancer cell lines MCF-7 and multidrug resistant (MDR) subline
MCF-7/Dx [60]. Respective synthetic analogs S-butyl butane-1-sulfinothioate and S-4-methoxyphenyl-
4-methoxybenzenesulfinothioate (Figure 3A,B) were identified as lead anticancer agents, having greater
potency than that of allicin.
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butane-1-sulfinothioate, (B) S-4-methoxyphenyl 4-methoxybenzenesulfinothioate [60], and (C) novel
antithrombotic agent difluoroallicin [61].
Of the tested aromatic thiosulfinates, anticancer activity was correlated with the substituent
attached to the sulfenyl sulfur moiety. Those molecules have an electron-rich 4-methoxybenzyl
group and are anti-proliferative in mammalian cells. Further assessment of S-4-methoxyphenyl-
4-methoxybenzenesulfinothioate showed this compound to inhibit cell proliferation by inducing
G2/M phase cell-cycle arrest and apoptosis in drug-resistant cells. Finally, the synthesis, reactivity,
and anti-thrombotic and anti-angiogenesis activity of a fluorinated allicin derivative have recently
been tested [61]. Difluoroallicin (S-(2-fluoroallyl) 2-fluoroprop-2-ene-1-sulfinothioate; Figure 3C)
dose-dependently inhibited angiogenesis and suppressed platelet aggregation [61].
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3.2. Ajoene Derivatives
Ajoene (Figure 4A) is a common component of oil macerates of garlic and is present in aged
crushed-garlic preparations [62]. The vinyl sulfur atom located within its disulfide backbone is
electrophilic [63] and reacts with nucleophilic thiols groups. Indeed, past work has shown ajoene
to react with cysteine residues present in and on proteins such as in glutathione reductase [64],
trypanothione reductase [64], and human gastric lipase [65]. The ability of this molecule to react
with thiol residues is partly responsible for its antimicrobial and anticancer properties [63,66,67].
Several ajoene-based analogs retain the central vinyl disulfide/sulfoxide core but have a variable
terminal end group. Recent studies indicate that the antimicrobial properties of ajoene can be partly
explained by its ability to disrupt quorum sensing (QS) in bacteria like in the pathogenic bacterium
Pseudomonas aeruginosa via reducing the expression of key virulence genes [68]. This property suggests
that ajoene and associated analogs could be useful antimicrobial agents. To date, one structure–activity
relationship (SAR) screened 25 disulfide bond-containing ajoene analogs [69]. Synthesis started with
the replacement of the allyl group with differing aliphatic and aromatic groups coupled with the
retention of the benzothiazole disulfide moiety. This work lead to the discovery of a number of
active antimicrobial agents, all of which required the presence of the benzothiazole group for activity.
Para-chlorophenyl derivative 2-((4-chlorophenyl)disulfanyl)benzothiazole significantly reduced the
levels of QS-regulated virulence factors like elastase, rhamnolipid, and pyocyanin and inhibited
P. aeruginosa infection in a murine model of implant-associated infection [69].
Some ajoene derivatives act as anticancer agents [70]. As shown in Table S1, a number of ajoene
derivatives containing the central vinyl disulfide/sulfoxide core are cytotoxic to cancer cells. The
para-methoxybenzyl (bisPMB) molecule (Figure 4B) and associated derivatives are anti-proliferative
when tested in transformed CT-1 fibroblast cells. These same compounds also inhibited cancer-cell
proliferation when tested on cultured prostrate, breast, cervical, and esophageal cancer cells [71,72].
Interestingly, analogs lacking the disulfide bond were inactive, indicating that the vinyl sulfur atom is
important for biological activity. Mechanistic work indicates that bisPMB induces alternate splicing of
transcription factor XBP-1 and alters the expression of ER stress proteins GRP78 and CHOP/GADD153,
CHOP expression being central to the cytotoxicity of this molecule [73]. Other research has led to
the identification and characterization of another ajoene derivative, SPA3015 (Figure 4C). SPA3015
reduces cell viability in P-gp-overexpressing MDR cancer cells, and suppresses NF-κB signaling. The
inhibition of NF-κB decreases expression of anti-apoptotic proteins, the cellular inhibitor of apoptosis
protein-1 (CIAP1), the cellular inhibitor of apoptosis protein-1 (CIAP2), the X-linked inhibitor of
apoptosis protein (XIAP), and B-cell lymphoma-extra large protein (Bcl-XL), [74]. Of equal importance
are efforts to identify cellular targets modified by ajoene. Kaschula and colleagues reported on the total
synthesis of two fluorescently tagged ajoene probes. These probes allowing researchers to track the
movement and localization of ajoene in cancer cells. Both a dansyl-tagged ajoene (DP; Figure 4D) and
a fluorescein-tagged ajoene (FOX; Figure 4E) were used to study the localizes of ajoene in mammalian
breast-cancer cells [75]. Dansyl ajoene, S-thiolates cellular proteins, and the use of this compound
reportedly allowed for the identification of vimentin as a cellular target prone to ajoene attack [76].
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3.3. Cysteine Analogs
Almost 20 years ago, Pinto and colleagues described the cytotoxic properties of a series of
synthetic S-cysteinyl compounds that resemble garlic constituents (Figure 5A–D). In this work, the
anti-proliferative effects of these compounds on human prostate carcinoma (LNCaP) cells were
reported [77].
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(B) benzyl-S-cysteine, (C) para-fluorobenzyl-S-cysteine, and (D) penta-1,3-dienyl-S-cysteine.
In the last decade, one of the most widely characterized cysteine analogs is S-propylargyl cysteine
(SPRC; Figure 6) identified after an initial screening of several analogs of S-allylcysteine [78,79].
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Figure 6. (A) S-propylcysteine, (B) S-allylcysteine, (C) S-propargylcysteine, three widely characterized
cysteine analogs. (D) Dual H2S and NO hybrid molecule ZYZ803. (E) Leonurine–SPRC conjugate,
3,5-dimethoxy-4-(2-amino-3-prop-2-ynylsulfanyl-propionyl)-benzoic acid 4-guan dino-butyl ester.
This m lecule has cardioprotective effect against hypoxia-induced neonatal rat ventricular myocyte
damage [80].
The pharmacological effects of SPRC are associated with its cardiopr tective and proa giogenic
properties as determined in several ischemic heart models. Studies show that SPRC is neuroprotective
when tested in a model of Alzheimer’s disease [81,82], has anticancer effects [83,84], and is
anti-inflammatory [85]. In the cardiovascular system SPRC reduces infarct size, improves cardiac
function, and mitigates the production and damaging effects of oxidative stress. These effects are
associated with the induction of antioxidant defenses in cardiac tissue, including catalase and superoxide
dismutase, and changes in the circulatory levels of H2S gas via the upregulation of H2S biosynthetic
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enzyme cystathionine-gamma-lyase (CSE), [82]. Additional research has confirmed the cardioprotective
effects of SPRC in animal models of heart failure [86], myocardial infarction [87], doxorubicin-induced
cardiotoxicity [88], hypoxic stress [89], and glucose-mediated damage [90]. When tested on primary
human umbilical vein endothelial cells, SPRC was proangiogenic via the activation of STAT3
signaling [91]. The anti-inflammatory effects of SPRC were linked to the inhibition of TNF-α-induced
ROS production and JNK1/2/NF-κB activation in cells, and reduced the expression of adhesion proteins
ICAM and VCAM in endothelial cells. In animal models, SPRC reduced inflammation in models of acute
pancreatitis in mice [92], alleviated inflammation anemia [93], and had anti-inflammatory effects in a
rodent model of rheumatoid arthritis by modulating Nrf2-ARE signaling [94]. Moreover, in heart failure,
SPRC preserves mitochondrial dysfunction through S-sulfhydration of Ca2+/calmodulin-dependent
protein kinase II (CAMKII) [95]. The same group recently developed a novel SPRC conjugate, designated
ZYZ-803, that functions as a combined H2S–NO-releasing molecule [96] (Figure 6D). ZYZ-803 contains
the H2S-releasing moiety of S-propargylcysteine (SPRC) combined with the NO-releasing group of
furoxan. Characterization of this ‘gas’ donor revealed that ZYZ-803 can time- and dose-dependently
relax the sustained contraction induced by phenylephrine in rat aortic rings, and has 1.5- to 100-fold
greater efficacy than that of furoxan or SPRC alone. Additional studies indicated that ZYZ-803 can
stimulate endothelial cell angiogenesis [97] via induction of STAT3 signaling and the activation of
CAMKII [98]. ZYZ-803 can improve left ventricular remodeling and preserve left ventricular function
in isoprenaline-induced heart failure in mice [99]. These protective effects corresponded with the
upregulation of CSE, an enzyme important for H2S generation, and the enzyme endothelial NO
synthase (eNOS) needed for NO production in cardiac tissue. Various endogenous antioxidant proteins,
like glutathione peroxidase (GPx) and heme oxygenase 1 (HO-1), also showed increased expression in
tissue. Lastly, ZYZ-803 treatment in animals mitigates endoplasmic reticulum stress-related necroptosis
following acute myocardial infarction [100].
3.4. Sulfide Species
Sulfides are common in many allium preparations, and compounds such as DADS, DATS, and allyl
methyl trisulfide (AMS) can occur in appreciable amounts in oils produced during steam distillation.
Garlic essential oils contain high amount of sulfur compounds like diallyl trisulfide (37.3–45.9%), diallyl
disulfide (17.5–35.6%), and methyl allyl trisulfide (7.7–10.4%) [101,102] (Figure 7A). Sadly, like other
allium-derived sulfur compounds, many sulfides are chemically reactive and prone to decomposition,
and this limits their use as viable therapeutic agents. Attention has been focused on the screening of
sulfide analogs as anti-proliferative agents in cancer cells [103], as inhibitors of HMG–CoA reductase,
which is a key enzyme in lipid metabolism [104,105], and as antimicrobial agents [106], (Figure 7B).
Research by Saini and colleagues identified bis[3-(3-fluorophenyl) prop-2-ene]disulphide from an
initial assessment of several synthetic DADs analogs. Bis[3-(3-fluorophenyl) prop-2-ene]disulfide
induces ROS generation, loss in mitochondrial membrane potential, and changes in the expression
of Bcl-2/Bax ratio, leading to the induction of apoptosis in human pancreatic cancer MIA PaCa-2
cells [107]. This compound caused G2/M phase cell-cycle arrest, and the upregulation of p-Chk1
and of inactive phosphorylated Cdc25C protein. Similarly, other synthetic sulfide derivatives appear
to be anti-proliferative in cancer cells, suggesting some commonality in their anti-proliferative
effects. This property appears to correspond with the induction of ROS production in cancer
cells [108,109] and the S-thiolation of intracellular proteins [110]. Other pronounced biological effects
of synthetic sulfide derivatives include neuroprotection by bis[2-(3,4-dimethoxy phenyl) ethenyl]
dithioperoxy anhydride and bis[2-(3-methoxy,4-hydroxy phenyl) ethenyl] dithioperoxy anhydride
derivatives (Figure 7C,D) [111,112], and cardioprotective properties [113]. In recent times, interest
in the development of H2S-releasing therapeutics has increased. As mentioned, compounds like
DATS can generate H2S gas, and this property is partly responsible for the biological effects attributed
to dietary foods containing this class of molecule [37,114–116]. H2S is the third gaseous signaling
molecule to be characterized, and it has a range of important biochemical and physiological roles in
Molecules 2019, 24, 4006 10 of 17
mammals [35,117]. With this in mind, several research groups have focused efforts on the development
of synthesis of H2S-releasing sulfides, particularly polysulfide species [118]. This work afforded the
synthesis of tetrasulfide species in high yields with little need for extensive purification. Several
bis(aryl) tetrasulfides and bis(alkyl) tetrasulfides, including N-acetylcysteine-derived tetrasulfides, were
produced. These approaches provide a convenient route for the production of several H2S-releasing
molecules. Similar efforts have led to the production of synthetic benzyl polysulfides (ranging from
monosulfide to tetrasulfide derivatives) that can release H2S in the presence of thiols like cysteine and
glutathione (Figure 7E,F). Both benzyl trisulfide and benzyl tetrasulfide also suppress cell proliferation
in bEnd.3 cells [119].
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4. Conclusions
Over the years, researchers have been fascinated with the isolation of functional components
present in the tissue of allium plants, and this has led to the characterization of a whole spectrum of
biologically active sulfur compounds. Less widely reported is the growing body of work focused on
the development of novel therapeutic agents based on naturally occurring sulfur species found in
alliums. Currently, this drive has focused on the identification and optimization of synthetic routes in
the production of derivatives of ajoene, S-allylcysteine, and various sulfide species. This research has
led to the production of several new antimicrobial and anticancer agents that are currently evaluated
in preclinical cell-culture and animal models. In the future, we anticipate that this field of research will
drive developments in the production of newer sulfur therapeutics.
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